Artigos de revistas sobre o tema "Clinical High-Risk State for Psychosis (CHR-P)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Clinical High-Risk State for Psychosis (CHR-P)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Ruas Resende, M. B., F. Agostinho, R. Nogueira, D. Cotovio, F. A. Silva e R. Lousada. "Ultra-High-Risk that do not transition to psychosis. What happens?" European Psychiatry 67, S1 (abril de 2024): S737. http://dx.doi.org/10.1192/j.eurpsy.2024.1533.
Texto completo da fonteRichter, Anja, Evangelos Vassos, Matthew J. Kempton, Mark van der Gaag, Lieuwe de Haan, Barnaby Nelson, Anita Riecher-Rössler et al. "S175. CLINICAL OUTCOMES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS RELATED TO INTERACTIONS BETWEEN POLYGENIC RISK SCORES AND CHILDHOOD ADVERSITY". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S104. http://dx.doi.org/10.1093/schbul/sbaa031.241.
Texto completo da fonteOmelchenko, M. "Premorbid of depressive youth at clinical high-risk for psychosis". European Psychiatry 65, S1 (junho de 2022): S683. http://dx.doi.org/10.1192/j.eurpsy.2022.1757.
Texto completo da fonteFusar-Poli, Paolo. "The Clinical High-Risk State for Psychosis (CHR-P), Version II". Schizophrenia Bulletin 43, n.º 1 (janeiro de 2017): 44–47. http://dx.doi.org/10.1093/schbul/sbw158.
Texto completo da fonteCleusix, Martine, Ines Khadimallah, Elodie Toffel, Paul Klauser, Kim Q. Do, Kerstin von Plessen, Philippe Conus e Alessandra Solida. "S69. CLINICAL HIGH RISK STATE: STRATIFICATION BASED ON CLINICAL PROFILE AND REDOX STATUS". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S60. http://dx.doi.org/10.1093/schbul/sbaa031.135.
Texto completo da fonteOmelchenko, M. A. "Clinical High Risk Psychosis: Issues of Diagnostics and Therapy". Psychiatry 18, n.º 2 (22 de julho de 2020): 82–91. http://dx.doi.org/10.30629/2618-6667-2020-18-2-82-91.
Texto completo da fonteLepock, Jennifer R., Romina Mizrahi, Michele Korostil, R. Michael Bagby, Elizabeth W. Pang e Michael Kiang. "Event-Related Potentials in the Clinical High-Risk (CHR) State for Psychosis: A Systematic Review". Clinical EEG and Neuroscience 49, n.º 4 (31 de janeiro de 2018): 215–25. http://dx.doi.org/10.1177/1550059418755212.
Texto completo da fontePoletti, Michele. "Early Intervention Services for youth at Clinical High-Risk for Psychosis: The Reggio Emilia At-Risk Mental State (ReARMS) experience". RIVISTA SPERIMENTALE DI FRENIATRIA 146, n.º 3 (dezembro de 2022): 61–80. http://dx.doi.org/10.3280/rsf2022-003004.
Texto completo da fonteOliver, Dominic, Giulia Spada, Joaquim Radua, Philip McGuire e Paolo Fusar-Poli. "M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S187. http://dx.doi.org/10.1093/schbul/sbaa030.448.
Texto completo da fonteSkuhareuskaya, M., e O. Skugarevsky. "Predictors of transition to psychosis in individuals at clinical high-risk for psychosis". European Psychiatry 41, S1 (abril de 2017): s838. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1651.
Texto completo da fonteKotlicka-Antczak, Magdalena, Michał S. Karbownik, Konrad Stawiski, Agnieszka Pawełczyk, Natalia Żurner, Tomasz Pawełczyk, Dominik Strzelecki e Paolo Fusar-Poli. "Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state". European Psychiatry 58 (11 de março de 2019): 72–79. http://dx.doi.org/10.1016/j.eurpsy.2019.02.007.
Texto completo da fonteZhen, Mao, Qijing Bo, Qing Tian, Fang Dong, Xianbin Li e Chuanyue Wang. "T37. PREPULSE INHIBITION IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA AND CLINICAL-HIGH RISK WITHOUT FAMILY HISTORY OF PSYCHOSIS". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S245—S246. http://dx.doi.org/10.1093/schbul/sbaa029.597.
Texto completo da fonteWei, Yanyan, Xiaochen Tang, Tingyu Zhang, Wenjun Su, Lihua Xu, Huiru Cui, Zhenying Qian, Tianhong Zhang e Jijun Wang. "Reduced temporal activation during a verbal fluency test in clinical high risk of psychosis: a functional near-infrared spectroscopy-based study". General Psychiatry 35, n.º 2 (abril de 2022): e100702. http://dx.doi.org/10.1136/gpsych-2021-100702.
Texto completo da fonteKim, Ahra, Minji Ha, Taekwan Kim, Sunghyun Park, Silvia Kyungjin Lho, Sun-Young Moon, Minah Kim e Jun Soo Kwon. "Triple-Network Dysconnectivity in Patients With First-Episode Psychosis and Individuals at Clinical High Risk for Psychosis". Psychiatry Investigation 19, n.º 12 (25 de dezembro de 2022): 1037–45. http://dx.doi.org/10.30773/pi.2022.0091.
Texto completo da fonteWadell, Paula. "62.2 Evidence-Based Treatment for Clinical High-Risk State for Psychosis (CHR-P) Syndromes". Journal of the American Academy of Child & Adolescent Psychiatry 61, n.º 10 (outubro de 2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.351.
Texto completo da fonteMenefee, Elizabeth. "62.1 Epidemiology and Diagnosis of Clinical High-Risk State for Psychosis (CHR-P) Syndromes". Journal of the American Academy of Child & Adolescent Psychiatry 61, n.º 10 (outubro de 2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.350.
Texto completo da fonteSalazar de Pablo, Gonzalo, Scott W. Woods, Georgia Drymonitou, Héctor de Diego e Paolo Fusar-Poli. "Prevalence of Individuals at Clinical High-Risk of Psychosis in the General Population and Clinical Samples: Systematic Review and Meta-Analysis". Brain Sciences 11, n.º 11 (20 de novembro de 2021): 1544. http://dx.doi.org/10.3390/brainsci11111544.
Texto completo da fonteHu, Yegang, Jun Wu, YuJiao Cao, XiaoChen Tang, GuiSen Wu, Qian Guo, LiHua Xu et al. "Abnormal neural oscillations in clinical high risk for psychosis: a magnetoencephalography method study". General Psychiatry 35, n.º 2 (abril de 2022): e100712. http://dx.doi.org/10.1136/gpsych-2021-100712.
Texto completo da fonteWorthington, Michelle, Jean Addington, Carrie Bearden, Kristin Cadenhead, Barbara Cornblatt, Daniel Mathalon, Thomas McGlashan et al. "T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S274—S275. http://dx.doi.org/10.1093/schbul/sbaa029.676.
Texto completo da fonteDe Micheli, Andrea, Albertine van Lawick van Pabst, Enass Yossef, Philip McGuire e Paolo Fusar-Poli. "S154. TOBACCO SMOKING AND CLINICAL HIGH RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EVIDENCE". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S94—S95. http://dx.doi.org/10.1093/schbul/sbaa031.220.
Texto completo da fonteGuo, Joyce Y., Tara A. Niendam, Andrea M. Auther, Ricardo E. Carrión, Barbara A. Cornblatt, J. Daniel Ragland, Steven Adelsheim et al. "Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study". Psychological Medicine 50, n.º 13 (11 de setembro de 2019): 2230–39. http://dx.doi.org/10.1017/s0033291719002332.
Texto completo da fonteKhoury, Rita, e Henry A. Nasrallah. "Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?" Schizophrenia Research 199 (setembro de 2018): 31–38. http://dx.doi.org/10.1016/j.schres.2018.04.017.
Texto completo da fonteAndreou, Christina, e Stefan Borgwardt. "Structural and functional imaging markers for susceptibility to psychosis". Molecular Psychiatry 25, n.º 11 (17 de fevereiro de 2020): 2773–85. http://dx.doi.org/10.1038/s41380-020-0679-7.
Texto completo da fonteBreitborde, Nicholas J. K., Hossam Guirgis, Walter Stearns, Kristen M. Carpenter, Ghada Lteif, Jacob G. Pine, Nichole Storey, Heather Wastler e Aubrey M. Moe. "The Ohio State University Early Psychosis Intervention Center (EPICENTER) step-based care programme for individuals at clinical high risk for psychosis: study protocol for an observational study". BMJ Open 10, n.º 1 (janeiro de 2020): e034031. http://dx.doi.org/10.1136/bmjopen-2019-034031.
Texto completo da fonteCarrión, R. E., D. McLaughlin, A. M. Auther, R. Olsen, C. U. Correll e B. A. Cornblatt. "The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis". Psychological Medicine 45, n.º 15 (14 de julho de 2015): 3341–54. http://dx.doi.org/10.1017/s0033291715001233.
Texto completo da fonteModinos, Gemma, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong et al. "Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes". Neuropsychopharmacology 46, n.º 8 (3 de maio de 2021): 1468–74. http://dx.doi.org/10.1038/s41386-021-01019-0.
Texto completo da fonteMillman, Zachary B., James M. Gold, Vijay A. Mittal e Jason Schiffman. "The Critical Need for Help-Seeking Controls in Clinical High-Risk Research". Clinical Psychological Science 7, n.º 6 (23 de setembro de 2019): 1171–89. http://dx.doi.org/10.1177/2167702619855660.
Texto completo da fonteFranscini, M., N. Traber-Walker, F. Probst, M. Gerstenberg e S. Walitza. "Early detection and intervention of psychosis in children and adolescents in Zurich, Switzerland: Clinical Data from 2017-2022". European Psychiatry 66, S1 (março de 2023): S1075—S1076. http://dx.doi.org/10.1192/j.eurpsy.2023.2284.
Texto completo da fonteCiarleglio, Adam J., Gary Brucato, Michael D. Masucci, Rebecca Altschuler, Tiziano Colibazzi, Cheryl M. Corcoran, Francesca M. Crump et al. "A predictive model for conversion to psychosis in clinical high-risk patients". Psychological Medicine 49, n.º 07 (28 de junho de 2018): 1128–37. http://dx.doi.org/10.1017/s003329171800171x.
Texto completo da fontePanikratova, Y., E. Abdullina, I. Lebedeva, M. Omelchenko, D. Tikhonov e V. Kaleda. "Brain functional connectivity and local coherence in non-converters with clinical high risk for psychosis". European Psychiatry 66, S1 (março de 2023): S612—S613. http://dx.doi.org/10.1192/j.eurpsy.2023.1277.
Texto completo da fonteHaining, Kate, Gina Brunner, Ruchika Gajwani, Joachim Gross, Andrew Gumley, Stephen Lawrie, Matthias Schwannauer, Frauke Schultze-Lutter e Peter Uhlhaas. "S64. COGNITIVE IMPAIRMENTS AND PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S57—S58. http://dx.doi.org/10.1093/schbul/sbaa031.130.
Texto completo da fonteFusar-Poli, Paolo, Matteo Rocchetti, Alberto Sardella, Alessia Avila, Martina Brandizzi, Edgardo Caverzasi, Pierluigi Politi, Stephan Ruhrmann e Philip McGuire. "Disorder, not just state of risk: Meta-analysis of functioning and quality of life in people at high risk of psychosis". British Journal of Psychiatry 207, n.º 3 (setembro de 2015): 198–206. http://dx.doi.org/10.1192/bjp.bp.114.157115.
Texto completo da fonteTomyshev, A. S., I. Lebedeva, A. Dudina, P. Menshchikov, D. Kupriyanov e M. Omelchenko. "Reduced resting-state gamma-band power correlate with unaltered glutamate + glutamine levels in patients at clinical-high risk of psychosis". European Psychiatry 67, S1 (abril de 2024): S615. http://dx.doi.org/10.1192/j.eurpsy.2024.1280.
Texto completo da fonteIfrah, Chloe, Shaynna N. Herrera, Steven M. Silverstein, Cheryl M. Corcoran, James Gordon, Pamela D. Butler e Vance Zemon. "The Relationship between Clinical and Psychophysical Assessments of Visual Perceptual Disturbances in Individuals at Clinical High Risk for Psychosis: A Preliminary Study". Brain Sciences 14, n.º 8 (16 de agosto de 2024): 819. http://dx.doi.org/10.3390/brainsci14080819.
Texto completo da fonteZajac, Jennifer. "62.3 An Innovative Intensive Outpatient Program for Adolescents With Clinical High-Risk State for Psychosis (CHR-P) Syndromes". Journal of the American Academy of Child & Adolescent Psychiatry 61, n.º 10 (outubro de 2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.352.
Texto completo da fonteCollin, Guusje, Alfonso Nieto-Castanon, Martha Shenton, Ofer Pasternak, Sinead Kelly, Matcheri Keshavan, Larry Seidman et al. "S147. FUNCTIONAL BRAIN CONNECTIVITY DATA IMPROVE CLINICAL OUTCOME PREDICTION IN YOUTH AT RISK FOR PSYCHOSIS". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S92. http://dx.doi.org/10.1093/schbul/sbaa031.213.
Texto completo da fonteMongan, David, Melanie Föcking, Colm Healy, Subash Raj Susai, Gerard Cagney, Mary Cannon, Stanley Zammit et al. "T21. DEVELOPMENT OF PROTEOMIC PREDICTION MODELS FOR OUTCOMES IN THE CLINICAL HIGH RISK STATE AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE: MACHINE LEARNING ANALYSES IN TWO NESTED CASE-CONTROL STUDIES". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S238—S239. http://dx.doi.org/10.1093/schbul/sbaa029.581.
Texto completo da fonteNeuner, L. M., L. Hahn, J. Kambeitz, R. K. Salokangas, J. Hietala, A. Bertolino, S. Borgwardt et al. "Exploring Associations between Grey Matter Volume and Clinical High-Risk for Psychosis: A Transdiagnostic Study Utilizing the NAPLS-2 Risk Calculator in the PRONIA Cohort". European Psychiatry 67, S1 (abril de 2024): S271—S272. http://dx.doi.org/10.1192/j.eurpsy.2024.572.
Texto completo da fonteDeVylder, J. E., S. Ben-David, S. A. Schobel, D. Kimhy, D. Malaspina e C. M. Corcoran. "Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis". Psychological Medicine 43, n.º 2 (1 de junho de 2012): 259–68. http://dx.doi.org/10.1017/s0033291712001262.
Texto completo da fonteGraham-Sullivan, Patricia C. "62.4 Prevention and Therapy Approaches to Clinical High-Risk State for Psychosis (CHR-P) in an Intensive Outpatient Program". Journal of the American Academy of Child & Adolescent Psychiatry 61, n.º 10 (outubro de 2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.353.
Texto completo da fontePopovic, D., C. Weyer, A. Ruef, D. Dwyer, S. L. Griffiths, P. A. Lalousis, N. Koutsouleris e R. Upthegrove. "Neuroinflammation in Recent Onset Mental Health Disorders – Developing Multi-level Signatures of Early-stage Depression and Psychosis in Young Adults". European Psychiatry 67, S1 (abril de 2024): S45—S47. http://dx.doi.org/10.1192/j.eurpsy.2024.147.
Texto completo da fonteOliver, D., M. Kotlicka-Antczak, A. Minichino, G. Spada, P. McGuire e P. Fusar-Poli. "Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined prediction". European Psychiatry 49 (2018): 62–68. http://dx.doi.org/10.1016/j.eurpsy.2017.10.001.
Texto completo da fonteAzis, Matilda, Gregory P. Strauss, Elaine Walker, William Revelle, Richard Zinbarg e Vijay Mittal. "Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes". Schizophrenia Bulletin 45, n.º 5 (8 de dezembro de 2018): 1042–50. http://dx.doi.org/10.1093/schbul/sby177.
Texto completo da fonteDean, Derek J., Jessica A. Bernard, Katherine S. F. Damme, Randall O’Reilly, Joseph M. Orr e Vijay A. Mittal. "Longitudinal Assessment and Functional Neuroimaging of Movement Variability Reveal Novel Insights Into Motor Dysfunction in Clinical High Risk for Psychosis". Schizophrenia Bulletin 46, n.º 6 (14 de julho de 2020): 1567–76. http://dx.doi.org/10.1093/schbul/sbaa072.
Texto completo da fonteGlenthøj, L. B., M. Nielsen e M. Nordentoft. "Negative symptoms assessment in early intervention settings: Implications for early identification and treatment". European Psychiatry 64, S1 (abril de 2021): S36. http://dx.doi.org/10.1192/j.eurpsy.2021.124.
Texto completo da fonteJeon, Peter, Roberto Limongi, Sabrina D. Ford, Cassandra Branco, Michael Mackinley, Maya Gupta, Laura Powe, Jean Théberge e Lena Palaniyappan. "Glutathione as a Molecular Marker of Functional Impairment in Patients with At-Risk Mental State: 7-Tesla 1H-MRS Study". Brain Sciences 11, n.º 7 (17 de julho de 2021): 941. http://dx.doi.org/10.3390/brainsci11070941.
Texto completo da fonteTraber-Walker, Nina, Miriam Gerstenberg, Sibylle Metzler, Claudia Bühlmann, Yolanda Blumenthal, Susanne Walitza e Maurizia Franscini. "O1.1. ETRo: EVALUATION OF THE TREATMENT APPROACH “ROBIN” (STANDARDIZED MANUAL AND SMARTPHONE APP) FOR ADOLESCENTS WITH CLINICAL HIGH RISK FOR DEVELOPING A PSYCHOTIC DISORDER". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S1. http://dx.doi.org/10.1093/schbul/sbaa028.000.
Texto completo da fonteFusar-Poli, Paolo, Andrea De Micheli, Rashmi Patel, Lorenzo Signorini, Syed Miah, Thomas Spencer e Philip McGuire. "Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study". Schizophrenia Bulletin 46, n.º 5 (18 de abril de 2020): 1114–25. http://dx.doi.org/10.1093/schbul/sbaa040.
Texto completo da fonteRosen, Marlene, Nathalie Kaiser, Linda Betz, Theresa Haidl, Mauro Seves, Tanja Pilgram, Frauke Schultze-Lutter et al. "S219. SINGLE-SUBJECT PREDICTION OF FUNCTIONAL OUTCOMES ACROSS DIAGNOSTIC GROUPS USING CLINICAL DATA". Schizophrenia Bulletin 46, Supplement_1 (abril de 2020): S122. http://dx.doi.org/10.1093/schbul/sbaa031.285.
Texto completo da fonteHasmi, Laila, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak, Gunter Kenis et al. "What makes the psychosis ‘clinical high risk’ state risky: psychosis itself or the co-presence of a non-psychotic disorder?" Epidemiology and Psychiatric Sciences 30 (2021). http://dx.doi.org/10.1017/s204579602100041x.
Texto completo da fonte